["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit]

Lakartidningen. 2007;104(48):3640-2.
[Article in Swedish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Cerebral Hemorrhage / chemically induced
  • Clopidogrel
  • Cyclohexanols / administration & dosage
  • Cyclohexanols / adverse effects
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Fatal Outcome
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / surgery
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Risk Factors
  • Stents
  • Ticlopidine / administration & dosage
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Venlafaxine Hydrochloride
  • Warfarin / administration & dosage*
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Cyclohexanols
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Venlafaxine Hydrochloride
  • Clopidogrel
  • Ticlopidine
  • Aspirin